Literature DB >> 30275018

AKT and AMP-activated protein kinase regulate TBC1D1 through phosphorylation and its interaction with the cytosolic tail of insulin-regulated aminopeptidase IRAP.

Samaneh Mafakheri1, Ralf R Flörke1, Sibylle Kanngießer2, Sonja Hartwig1, Lena Espelage1, Christian De Wendt1, Tina Schönberger2, Nele Hamker2, Stefan Lehr1, Alexandra Chadt1, Hadi Al-Hasani3.   

Abstract

In skeletal muscle, the Rab GTPase-activating (GAP) protein TBC1D1 is phosphorylated by AKT and AMP-activated protein kinase (AMPK) in response to insulin and muscle contraction. Genetic ablation of Tbc1d1 or mutation of distinct phosphorylation sites impairs intracellular GLUT4 retention and GLUT4 traffic, presumably through alterations of the activation state of downstream Rab GTPases. Previous studies have focused on characterizing the C-terminal GAP domain of TBC1D1 that lacks the known phosphorylation sites, as well as putative regulatory domains. As a result, it has been unclear how phosphorylation of TBC1D1 would regulate its activity. In the present study, we have expressed, purified, and characterized recombinant full-length TBC1D1 in Sf9 insect cells via the baculovirus system. Full-length TBC1D1 showed RabGAP activity toward GLUT4-associated Rab8a, Rab10, and Rab14, indicating similar substrate specificity as the truncated GAP domain. However, the catalytic activity of the full-length TBC1D1 was markedly higher than that of the GAP domain. Although in vitro phosphorylation of TBC1D1 by AKT or AMPK increased 14-3-3 binding, it did not alter the intrinsic RabGAP activity. However, we found that TBC1D1 interacts through its N-terminal PTB domains with the cytoplasmic domain of the insulin-regulated aminopeptidase, a resident protein of GLUT4 storage vesicles, and this binding is disrupted by phosphorylation of TBC1D1 by AKT or AMPK. In summary, our findings suggest that other regions outside the GAP domain may contribute to the catalytic activity of TBC1D1. Moreover, our data indicate that recruitment of TBC1D1 to GLUT4-containing vesicles and not its GAP activity is regulated by insulin and contraction-mediated phosphorylation.
© 2018 Mafakheri et al.

Entities:  

Keywords:  Rab10; RabGAPs; Type 2 diabetes; glucose transport; glucose transporter type 4 (GLUT4); insulin; skeletal muscle

Mesh:

Substances:

Year:  2018        PMID: 30275018      PMCID: PMC6240868          DOI: 10.1074/jbc.RA118.005040

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  43 in total

1.  Biochemical characterization of Gyp6p, a Ypt/Rab-specific GTPase-activating protein from yeast.

Authors:  E Will; D Gallwitz
Journal:  J Biol Chem       Date:  2001-01-12       Impact factor: 5.157

2.  Endocytosis of the glucose transporter GLUT4 is mediated by the GTPase dynamin.

Authors:  H Al-Hasani; C S Hinck; S W Cushman
Journal:  J Biol Chem       Date:  1998-07-10       Impact factor: 5.157

Review 3.  Regulation of RabGAPs involved in insulin action.

Authors:  Samaneh Mafakheri; Alexandra Chadt; Hadi Al-Hasani
Journal:  Biochem Soc Trans       Date:  2018-05-21       Impact factor: 5.407

4.  Insulin-stimulated GLUT4 protein translocation in adipocytes requires the Rab10 guanine nucleotide exchange factor Dennd4C.

Authors:  Hiroyuki Sano; Grantley R Peck; Arminja N Kettenbach; Scott A Gerber; Gustav E Lienhard
Journal:  J Biol Chem       Date:  2011-03-22       Impact factor: 5.157

5.  Calmodulin-binding domain of AS160 regulates contraction- but not insulin-stimulated glucose uptake in skeletal muscle.

Authors:  Henning F Kramer; Eric B Taylor; Carol A Witczak; Nobuharu Fujii; Michael F Hirshman; Laurie J Goodyear
Journal:  Diabetes       Date:  2007-08-23       Impact factor: 9.461

6.  Detection of in vitro kinase generated protein phosphorylation sites using gamma[18O4]-ATP and mass spectrometry.

Authors:  Ming Zhou; Zhaojing Meng; Andrew G Jobson; Yves Pommier; Timothy D Veenstra
Journal:  Anal Chem       Date:  2007-09-18       Impact factor: 6.986

7.  A role for Rab14 in the endocytic trafficking of GLUT4 in 3T3-L1 adipocytes.

Authors:  Sam E Reed; Lorna R Hodgson; Shuang Song; Margaret T May; Eoin E Kelly; Mary W McCaffrey; Cynthia C Mastick; Paul Verkade; Jeremy M Tavaré
Journal:  J Cell Sci       Date:  2013-02-26       Impact factor: 5.285

8.  Tbc1d1 mutation in lean mouse strain confers leanness and protects from diet-induced obesity.

Authors:  Alexandra Chadt; Katja Leicht; Atul Deshmukh; Lake Q Jiang; Stephan Scherneck; Ulrike Bernhardt; Tanja Dreja; Heike Vogel; Katja Schmolz; Reinhart Kluge; Juleen R Zierath; Claus Hultschig; Rob C Hoeben; Annette Schürmann; Hans-Georg Joost; Hadi Al-Hasani
Journal:  Nat Genet       Date:  2008-10-19       Impact factor: 38.330

9.  R125W coding variant in TBC1D1 confers risk for familial obesity and contributes to linkage on chromosome 4p14 in the French population.

Authors:  David Meyre; Morgane Farge; Cécile Lecoeur; Christine Proenca; Emmanuelle Durand; Frédéric Allegaert; Jean Tichet; Michel Marre; Beverley Balkau; Jacques Weill; Jérôme Delplanque; Philippe Froguel
Journal:  Hum Mol Genet       Date:  2008-03-05       Impact factor: 6.150

10.  A Rab10:RalA G protein cascade regulates insulin-stimulated glucose uptake in adipocytes.

Authors:  Sheelarani Karunanithi; Tingting Xiong; Maeran Uhm; Dara Leto; Jingxia Sun; Xiao-Wei Chen; Alan R Saltiel
Journal:  Mol Biol Cell       Date:  2014-08-07       Impact factor: 4.138

View more
  14 in total

Review 1.  Thirty sweet years of GLUT4.

Authors:  Amira Klip; Timothy E McGraw; David E James
Journal:  J Biol Chem       Date:  2019-06-07       Impact factor: 5.157

Review 2.  Endosomal trafficking in metabolic homeostasis and diseases.

Authors:  Jerome Gilleron; Anja Zeigerer
Journal:  Nat Rev Endocrinol       Date:  2022-10-10       Impact factor: 47.564

3.  Cooperative actions of Tbc1d1 and AS160/Tbc1d4 in GLUT4-trafficking activities.

Authors:  Hiroyasu Hatakeyama; Taisuke Morino; Takuya Ishii; Makoto Kanzaki
Journal:  J Biol Chem       Date:  2018-11-27       Impact factor: 5.157

Review 4.  Glucose transporters in adipose tissue, liver, and skeletal muscle in metabolic health and disease.

Authors:  Alexandra Chadt; Hadi Al-Hasani
Journal:  Pflugers Arch       Date:  2020-06-26       Impact factor: 3.657

5.  microRNA-519d Induces Autophagy and Apoptosis of Human Hepatocellular Carcinoma Cells Through Activation of the AMPK Signaling Pathway via Rab10.

Authors:  Yi-Jie Zhang; Qi Pan; Yang Yu; Xin-Ping Zhong
Journal:  Cancer Manag Res       Date:  2020-04-15       Impact factor: 3.989

6.  Insulin-responsive amino peptidase follows the Glut4 pathway but is dispensable for the formation and translocation of insulin-responsive vesicles.

Authors:  Xiang Pan; Anatoli Meriin; Guanrong Huang; Konstantin V Kandror
Journal:  Mol Biol Cell       Date:  2019-04-03       Impact factor: 4.138

Review 7.  Metabolic Heterogeneity of Cancer Cells: An Interplay between HIF-1, GLUTs, and AMPK.

Authors:  Nurbubu T Moldogazieva; Innokenty M Mokhosoev; Alexander A Terentiev
Journal:  Cancers (Basel)       Date:  2020-04-02       Impact factor: 6.639

8.  AMPK-mediated phosphorylation enhances the auto-inhibition of TBC1D17 to promote Rab5-dependent glucose uptake.

Authors:  Xi Sheng Rao; Xiao Xia Cong; Xiu Kui Gao; Yin Pu Shi; Lin Jing Shi; Jian Feng Wang; Chen-Yao Ni; Ming Jie He; Yingke Xu; Cong Yi; Zhuo-Xian Meng; Jinling Liu; Peng Lin; Li Ling Zheng; Yi Ting Zhou
Journal:  Cell Death Differ       Date:  2021-05-27       Impact factor: 15.828

Review 9.  The Role of Insulin Regulated Aminopeptidase in Endocytic Trafficking and Receptor Signaling in Immune Cells.

Authors:  Delphyne Descamps; Irini Evnouchidou; Vivien Caillens; Carole Drajac; Sabine Riffault; Peter van Endert; Loredana Saveanu
Journal:  Front Mol Biosci       Date:  2020-10-20

10.  TBC1D1 interacting proteins, VPS13A and VPS13C, regulate GLUT4 homeostasis in C2C12 myotubes.

Authors:  Sharon C Hook; Alexandra Chadt; Kate J Heesom; Shosei Kishida; Hadi Al-Hasani; Jeremy M Tavaré; Elaine C Thomas
Journal:  Sci Rep       Date:  2020-10-21       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.